摘要
肿瘤坏死因子α诱导蛋白8样分子2(TIPE2)可负性调控固有免疫及适应性免疫系统,并通过影响多种信号通路参与肝炎、肝硬化、肝细胞癌等肝脏疾病的发生和发展过程。总结目前TIPE2参与不同肝病发病机制的现有研究,认为TIPE2可能成为治疗不同肝脏疾病的一个新靶点。
Tumor necrosis factor-alpha-induced protein 8-like 2 (TIPE2) can negatively regulate innate immunity and adaptive immunity and participate in the development and progression of various liver diseases, such as hepatitis, liver cirrhosis, and hepatocellular carcinoma, by affecting a variety of signaling pathways. This article summarizes the current research on the involvement of TIPE2 in the pathogenesis of different liver diseases and points out that TIPE2 may become a new target for the treatment of liver diseases.
作者
王闪闪
张庆山
赵素贤
孔令波
纪雷
孔丽
WANG Shanshan;ZHANG Qingshan;ZHAO Suxian(Hebei Provincial Key Laboratory for Research on Pathogenesis of Chronic Liver Diseases and Liver Fibrosis, Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China)
出处
《临床肝胆病杂志》
CAS
北大核心
2020年第2期460-463,共4页
Journal of Clinical Hepatology
基金
河北省卫生厅课题(ZL20140032)
河北省中医药管理局课题(2014142)
